NEW YORK, NY--(Marketwire - Nov 16, 2012) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
ARMOUR Residential REIT, Inc. (NYSE: ARR) shares rebounded 5.5% Thursday on over 20 million shares traded. The company currently offers investors an annual dividend of $1.08 per share for a yield of approximately 17.7%.
Find out more about ARMOUR Residential REIT including full access to the free equity report at: www.BedfordReport.com/ARR
DryShips Inc. (NASDAQ: DRYS) shares fell 17% on nearly 18 million shares traded Thursday. The company's net loss widened to $51.3 million in the third quarter of 2012. Dryships have recently stated that their focus is on reducing and prolonging its capital expenditure program.
Find out more about DryShips including full access to the free equity report at: www.BedfordReport.com/DRYS
ImmunoCellular Therapeutics Ltd. (NYSE: IMUC) is a clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The company's ICT-107 cancer vaccine is anticipated to complete a Phase IIb trial at the end of 2013.
Find out more about ImmunoCellular Therapeutics including full access to the free equity report at: www.BedfordReport.com/IMUC
Solazyme Inc. (NASDAQ: SZYM) shares saw its largest gain in over a year on over 3 times the average daily volume Thursday. The company has announced expansion plans with partners ADM and Bunge.
Find out more about Solazyme including full access to the free equity report at: www.BedfordReport.com/SZYM
Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release.